Jonathan D. Root, Director, 10% Owner at eFFECTOR Therapeutics, Inc. (EFTR), sold 41,605 shares at $9.42 ($388K) on 2021-11-16, disclosed to the SEC on 2021-11-17.
Open-market sale of $388k EFTR by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.81 | 157 | $2K | 0.4% |
| 2 | $9.81 | 4,914 | $48K | 12.4% |
| 3 | $9.42 | 257 | $2K | 0.6% |
| 4 | $9.42 | 8,062 | $76K | 19.6% |
| 5 | $9.42 | 8,062 | $76K | 19.6% |
| 6 | $9.13 | 317 |
| $3K |
| 0.7% |
| 7 | $9.13 | 9,918 | $91K | 23.3% |
| 8 | $9.13 | 9,918 | $91K | 23.3% |
| Total | $9.33 avg | 41,605 | $388K | 100% |
| Filing → |
| NARI | BUY | 2022-03-18 | $28K | — | Filing → |
| SBTX | BUY | 2022-03-18 | $36K | — | Filing → |
| EFTR | SELL | 2021-12-06 | $46K | — | Filing → |